Medical, ethical and legal issues regarding thrombolytic therapy in the Jehovah's Witness
- 1 December 1991
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (15), 1525-1529
- https://doi.org/10.1016/0002-9149(91)90290-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The role of the emergency physician in the management of Jehovah's WitnessesAnnals of Emergency Medicine, 1989
- Coronary Thrombolysis— It's Worth the RiskPublished by American Medical Association (AMA) ,1989
- The risk of reperfusion strategies in the treatment of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1988
- Reperfusion therapy in inferior myocardial infarctionJournal of the American College of Cardiology, 1988
- Coronary Angioplasty for Acute Myocardial InfarctionAnnals of Internal Medicine, 1988
- The Inner Workings of an Ethics Committee: Latest Battle over Jehovah's WitnessesThe Hastings Center Report, 1988
- Thrombolysis in the Treatment of Acute Transmural Myocardial InfarctionAnnals of Internal Medicine, 1987
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Coronary Thrombolysis for Evolving Myocardial InfarctionDrugs, 1984
- Ethical and Cultural Dimensions of Informed ConsentAnnals of Internal Medicine, 1982